Valproic acid is one of the most common antiepileptic drugs used for the treatment of several seizure disorders. A 20-year-old man presented with a sudden decline of consciousness. He had a neurosurgery operation for intracranial and intraventricular hemorrhage. Following surgery, antiepileptic medication was administered to the patient in order to control his seizure events. On valproic acid treatment, he began to complain of fever and dyspnea. His symptoms persisted despite receiving empirical antibiotic treatment. All diagnostic tests for infectious causes were negative. A highresolution computed tomography scan of the chest revealed predominantly dependent consolidation and ground-glass opacities in both lower lobes. The primary differential was drug associated with interstitial lung disease. Therefore, we discontinued valproic acid treatment and began methylprednisolone treatment. His symptoms and radiologic findings had significantly improved after receiving steroid therapy. We propose that clinicians should be made aware of the potential for valproic acid to induce lung injury.
treatment of manic episodes associated with bipolar disorder, as an adjunctive therapy in multiple types of seizures, and for the prophylaxis of migraine headaches.
Valproic acid is known to induce several adverse effects involving the hepatobiliary, renal, neurologic, hematologic, cardiovascular, gastrointestinal, and metabolic systems 1 . However, adverse effects of valproic acid on the pulmonary system, including acute eosinophilic effusion or diffuse alveolar hemorrhage, have rarely been reported. Further, interstitial lung disease caused by valproic acid has not been previously reported. Herein, we describe a patient with drug-induced interstitial pneumonitis caused by valproic acid administered to treat seizures.
Introduction
Valproic acid is one of the most common antiepileptic drugs used for the treatment of several seizure disorders. (Figure 1) . A brain computed tomography revealed intracranial and intraventricular hemorrhage. The patient was admitted to the department of neurosurgery, and a surgical procedure was performed.
Following surgery, the patient was administered anti-hypertensive medication (nicardipine, 2 mg/hr, intravenous) and antibiotics (ceftriaxone, 2 g every 24 hours), as well as intravenous vitamin K (10 mg, every 8 hours) and tranexamic acid (500 mg, every 8 hours) to control bleeding. On day six following hospitalization, antiepileptic medication was administered to the patient to control his seizure events (sodium valproate, 400 mg, every 8 hours). On day fourteen following hospitalization, the patient' s neurologic symptoms were improved. How- (Figure 2A ). In addition, a high-resolution computed tomography (HRCT) scan of the chest revealed predominantly dependent consolidation with air bronchogram and ground-glass opacities in both lower lobes ( Figure 2B ).
The patient required mechanical ventilation support due to the rapid and progressive aggravation of clinical symptoms. Hence, administration of empirical antibiotic therapy for hospital-acquired pneumonia was commenced (meropenem, 1 g every 8 hours, and levofloxacin, 750 mg every 24 hours). Despite two days of antibiotic therapy, the patient' s radiologic and clinical findings persisted. Consequently, bronchoscopy with bronchoalveolar lavage was performed at the superior segment of the right lower lobe. Bronchoalveolar lavage fluid differential cell counts were as follows: white blood cell, 1,780 cells/μL (neutrophils 83%, lymphocytes 15%, macrophage 1%, eosinophils 1%, and basophils 0%); and red blood cell, 11,350 cells/μL. The bronchoscopic washing specimens were negative for Mycobacterium tuberculosis, as determined by the acid-fast bacilli smear, polymerase chain reaction, and microbial cultures. Based on the clinical symptoms and the low procalcitonin level, a diagnosis of drug-induced interstitial lung disease (DILD) was suspected. Thus, valproic acid treatment was discontinued, and treatment with methylprednisolone 50 mg (1 mg/kg of body weight) was initiated. After three days of steroid therapy, the patient's symptoms and radiological findings had significantly improved. The dosage of methylprednisolone was gradually decreased to 10 mg daily for two weeks. Two weeks later, a HRCT of chest revealed complete remission, and indicated no sign of bilateral infiltrates ( Figure  3 ).
Discussion
Valproic acid is one of the most common antiepileptic drugs used for the treatment of several seizure disorders. However, valproic acid is known to induce several adverse effects involving the hepatobiliary, renal, neurologic, hemato- www.e-trd.org logic, cardiovascular, gastrointestinal, and metabolic systems. Adverse pulmonary effects associated with valproic acid, such as diffuse alveolar hemorrhage or eosinophilic effusion, have rarely been reported. Additionally, we found no reports in the literature of any association between valproic acid administration and interstitial lung disease [2] [3] [4] . Several types of drugs can cause DILD. However, the associated incidence of DILD varies for each individual drug. DILD may be mild to progressive, and in its more severe manifestation, DILD may result in respiratory failure and acute respiratory distress syndrome. Further, DILD may develop within the first few days of treatment, or may not manifest until several years after treatment.
Diagnosis of DILD generally depends on a definite temporal association between exposure to the causative agent, and the development of respiratory signs and symptoms. Specific markers, histological findings, and diagnostic clinical features are generally unremarkable in DILD 5, 6 . Difficulties arise when signs and symptoms develop after the drug is discontinued, rather than during treatment, or when no improvement follows discontinuation of the drug. Making a timely and accurate diagnosis of DILD is very important to ensure a favorable outcome 7 . Most importantly, for an accurate diagnosis, other causes of lung damage such as presence of infectious disease must be excluded 8, 9 . A pathological examination was not performed on the patient in the current case report. However, infectious pathogens were excluded as the cause of interstitial pneumonia, as a microbial culture was negative for infectious bacteria. In addition, the patient' s symptoms and infiltrations on chest radiography occurred soon after initiating treatment with valproic acid. After discontinuing valproic acid and initiating steroid therapy, the patient' s symptoms and radiological findings had improved. Therefore, the patient was diagnosed with interstitial lung disease caused by valproic acid administration. Accordingly, we propose that clinicians should be made aware of the potential for valproic acid to induce lung injury.
In addition, the administration of valproic acid for the treatment of seizure disorders may require special attention.
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